121 related articles for article (PubMed ID: 38441600)
21. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
Yue H; Li W; Chen R; Wang J; Lu X; Li J
Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
[TBL] [Abstract][Full Text] [Related]
22. Role of periostin in skin wound healing and pathologic scar formation.
Yin SL; Qin ZL; Yang X
Chin Med J (Engl); 2020 Sep; 133(18):2236-2238. PubMed ID: 32769490
[No Abstract] [Full Text] [Related]
23. The usefulness of periostin determination in gynecology and obstetrics.
Kobierzycki C; Latkowski KJ; Dziegiel P
Ginekol Pol; 2020; 91(6):364-351. PubMed ID: 32627156
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and management of uterine fibroids.
Giuliani E; As-Sanie S; Marsh EE
Int J Gynaecol Obstet; 2020 Apr; 149(1):3-9. PubMed ID: 31960950
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
[TBL] [Abstract][Full Text] [Related]
26. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.
Munro MG; Critchley HOD; Fraser IS;
Int J Gynaecol Obstet; 2018 Dec; 143(3):393-408. PubMed ID: 30198563
[TBL] [Abstract][Full Text] [Related]
27. Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression.
González-González L; Alonso J
Front Oncol; 2018; 8():225. PubMed ID: 29946533
[TBL] [Abstract][Full Text] [Related]
28. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
[TBL] [Abstract][Full Text] [Related]
29. Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy.
Kotani Y; Tobiume T; Fujishima R; Shigeta M; Takaya H; Nakai H; Suzuki A; Tsuji I; Mandai M; Matsumura N
J Obstet Gynaecol Res; 2018 Feb; 44(2):298-302. PubMed ID: 29227004
[TBL] [Abstract][Full Text] [Related]
30. Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.
Ciebiera M; Łukaszuk K; Męczekalski B; Ciebiera M; Wojtyła C; Słabuszewska-Jóźwiak A; Jakiel G
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194370
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
32. Endometrial ablation.
Munro MG
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():120-139. PubMed ID: 29128205
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of uterine fibroids: a systematic review.
Stewart EA; Cookson CL; Gandolfo RA; Schulze-Rath R
BJOG; 2017 Sep; 124(10):1501-1512. PubMed ID: 28296146
[TBL] [Abstract][Full Text] [Related]
34. Periostin Promotes Scar Formation through the Interaction between Pericytes and Infiltrating Monocytes/Macrophages after Spinal Cord Injury.
Yokota K; Kobayakawa K; Saito T; Hara M; Kijima K; Ohkawa Y; Harada A; Okazaki K; Ishihara K; Yoshida S; Kudo A; Iwamoto Y; Okada S
Am J Pathol; 2017 Mar; 187(3):639-653. PubMed ID: 28082119
[TBL] [Abstract][Full Text] [Related]
35. Uterine fibroid management: from the present to the future.
Donnez J; Dolmans MM
Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209
[TBL] [Abstract][Full Text] [Related]
36. Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway.
Zheng QM; Lu JJ; Zhao J; Wei X; Wang L; Liu PS
Biomed Res Int; 2016; 2016():9842619. PubMed ID: 27034956
[TBL] [Abstract][Full Text] [Related]
37. Infertility and uterine fibroids.
Zepiridis LI; Grimbizis GF; Tarlatzis BC
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():66-73. PubMed ID: 26856931
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
Protic O; Toti P; Islam MS; Occhini R; Giannubilo SR; Catherino WH; Cinti S; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
Cell Tissue Res; 2016 May; 364(2):415-27. PubMed ID: 26613601
[TBL] [Abstract][Full Text] [Related]
39. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
[TBL] [Abstract][Full Text] [Related]
40. Med12 gain-of-function mutation causes leiomyomas and genomic instability.
Mittal P; Shin YH; Yatsenko SA; Castro CA; Surti U; Rajkovic A
J Clin Invest; 2015 Aug; 125(8):3280-4. PubMed ID: 26193636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
